Press release
Hepatitis C Treatment Market by Drug class, Route of administration and Distribution channel. Market Leaders are GlaxoSmithKline, Bristol-Myers Squibb, F. Hoffmann- La Roche Ltd, Merck, Johnson & Johnson, Gilead Sciences, AbbVie, Vertex Pharmaceuticals an
The global Hepatitis C treatment market is boosting due to following factors-
• Increased cases and awareness about the HCV infection
• Government initiatives and various policies helping the cause
• Increasing fund in R & D activities
• New and innovative drug production
Though, absence of antibiotics, expensive medications, and dearth of hepatitis C infection awareness in underdeveloped countries can hamper the market growth of hepatitis C treatment globally.
Market summary:
According to the World Health Organization (WHO), there are 80 Mn people worldwide suffering from chronic hepatitis C virus (HCV), in that approximately 700,000 will die each year as a result of the HCV infection. Collaborations, acquisitions and mergers, new product launches, increase in R & D activities, and sanctions for new products from various drug regulatory bodies such as U.S. FDA are some key tactics followed by various businesses to boost their market growth in global Hepatitis C treatment market.
Read more Insights at https://www.precisionbusinessinsights.com/market-reports/global-hepatitis-c-treatment-market/
Regional analysis
North America dominates the global hepatitis C infection market and is closely followed by Europe. Factors such as increased HCV infections, rise in awareness, rise in technological advancements and acceptance of newer products and more R&D activities are help grow the North America market.
According to European Center for Disease Prevention and Control approx. 5.9 million people are suffering from HCV infection. Other factors leading the European market growth for hepatitis C treatment market are increase in older population pool, lifestyle transformation, and unprotected sexual intercourse.
Avail sample report at https://bit.ly/2RUfDt3
Asia-Pacific hepatitis C treatment market is growing owing to increasing cases of HCV infection, rise in the population and increase in the healthcare set-up.
The Middle East & Africa region has highest cases of HCV infection mainly in Egypt that is approximately 8434 prevalent cases per 100,000 people.
Notable market development:
Mavyret (Glecaprevir/Pibrentasvir) by AbbVie received FDA approval in 2017 for treatment of chronic hepatitis C virus (HCV) infection in all major genotypes (GT1-6)
Some of the key players in the global Hepatitis C treatment market are
• GlaxoSmithKline, plc. (U.K.)
• Bristol-Myers Squibb (U.S)
• F. Hoffmann- La Roche Ltd. (Switzerland)
• Merck & Co, Inc. (U.S)
• Johnson & Johnson Services, Inc. (U.S.)
• Gilead Sciences (U.S.)
• AbbVie Inc. (U.S.)
• Vertex Pharmaceuticals Inc. (U.S.)
• Kadmon Holdings, Inc. (U.S.)
The global Hepatitis C treatment market is categorized on the basis of drug class, route of administration, end-users and geographical regions.
By drug class
• Polymerase Inhibitors
• NS5A Inhibitors
• Interferons
• HCV protease inhibitors
• Combination Therapy
By route of administration
• Oral
• Parenteral
By end-users
• Retail Pharmacies
• Hospital Pharmacies
• Others
By geographical regions
• North America
• Latin America
• Asia Pacific
• The Middle East and Africa
• Europe
About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.
Contact us
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: sales@precisionbusinessinsights.com
Toll Free (US):+1-866-598-1553
Website @https://www.precisionbusinessinsights.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Hepatitis C Treatment Market by Drug class, Route of administration and Distribution channel. Market Leaders are GlaxoSmithKline, Bristol-Myers Squibb, F. Hoffmann- La Roche Ltd, Merck, Johnson & Johnson, Gilead Sciences, AbbVie, Vertex Pharmaceuticals an here
News-ID: 1408070 • Views: …
More Releases from Precision Business Insights
Biochar Market Growth Is Attributed To The Increased Production Of Biochar Throu …
According to Precision Business Insights (PBI), the latest report biochar market was valued at USD 243.8 million in 2022, growing at a 12.6% CAGR during the forecast period 2023 to 2029. The rising demand for organic and eco-friendly products drives the biochar market. Utilizing biochar corresponds with organic farming methods, improving market prospects. Furthermore, biochar is a potential material for water treatment and remediation because of its capacity to absorb…
Vapor Recovery Units Market Growth Is Attributed To The Increased Adoption Of Me …
According to Precision Business Insights (PBI), latest report vapor recovery units market was valued at USD 923.7 million in 2022 and is poised to grow at a CAGR of 4.2% during the forecast period 2023 to 2029. The adoption of stringent environmental regulations by governments and international bodies to reduce air pollution and greenhouse gas emissions in various countries drives the demand for the vapor recovery unit's market. Furthermore, the…
Pyrite Market Growth Is Attributed To The Increased Demand In Jewelry Industry
According to Precision Business Insights (PBI), latest report pyrite market is growing at 4.9% CAGR during the forecast period 2023 to 2029. The increased application of pyrite in the manufacturing of sulfuric acid drives the pyrite market. The increase of prices of gold has led to increased demand for imitation jewelry which is anticipated to propel the pyrite market growth. Furthermore, the demand for sulphuric acid in a variety of…
Industrial Boilers Market Growth Is Attributed To The Increased Use In Power Gen …
According to Precision Business Insights (PBI), the latest report industrial boilers market size was valued at USD 15,261.8 million in 2022 and is poised to grow at a 3.1% CAGR during the forecast period 2023 to 2029. The adoption of stringent environmental regulations to maintain emission standards and carbon reduction in several countries drives the industrial boilers market. Furthermore, the advancement in boiler technology, such as better combustion systems, greater…
More Releases for Hepatitis
Is Hepatitis A Vaccine Required?
Hepatitis A Vaccine Market describes its growth, size, share, Forecast and trends to 2025
Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year.
Two types of HAV vaccines are currently available internationally:
1. Formaldehyde-inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are available…
Hepatitis Drugs Market Is Growing Due to Increasing R&D Investments on Hepatitis …
The global hepatitis drugs market is growing due to increasing incidences of hepatitis and increasing support from government organizations. In addition, the growing geriatric population, and increasing R&D investments on hepatitis research and drug discovery are also driving the growth of the global hepatitis drugs market.
Access Detailed Report Summary: https://www.psmarketresearch.com/market-analysis/hepatitis-drugs-market
Among the various types, the hepatitis C segment is expected to be the largest segment, and expected to witness the fastest…
Hepatitis B Therapeutics Market Is Driven by Rising Incidence of Hepatitis B In …
Hepatitis B is a life threatening liver infection caused by hepatitis B virus. Adults who get affected by hepatitis B virus for a short time and then get cured is known as acute hepatitis B. Infection that lasts for a long time is known as chronic hepatitis B. Vaccine is the most preferred choice of doctors and physicians to protect people from the disease. The vaccine prevents the infection and…
Hepatitis E Hyperendemicity to Drive Hepatitis E Diagnostic Tests Market Growth
Global Hepatitis E Diagnostic Tests Market: Snapshot
The growing incidence of hepatitis E, a liver disease caused by infection due to the virus hepatitis E virus (HEV), is a leading cause of morbidity and mortality worldwide. There is increasing prevalence of hepatitis E in resource-limited region, such as various countries of Asia Pacific. The people of these regions suffer with frequent water contamination and have limited access to sanitation and hygiene,…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
Hepatitis C Drug Pipeline Analysis
“Hepatitis C Drug Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various drug profiles being developed for the treatment of Hepatitis C. Research report covers all the ongoing drug development in various phases. Each drug profiles include detailed information like: Originator, Owner, Collaborator, Technology Provider, Licensee, Development Phase, Development Indications, Mechanism of Action, Chemical Formula, Country of Development and detailed analysis on the development process. Insight for each…
